Zentalis Pharmaceuticals Inc — 貸借対照表 (NASDAQ:ZNTL) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 365.56 M454.51 M539.31 M551.69 M430.34 M288.97 M 負債合計 32.18 M90.03 M105.29 M114.3 M93.15 M72.76 M 純資産合計 333.38 M364.48 M434.02 M437.39 M337.19 M216.2 M 負債および純資産合計 365.56 M454.51 M539.31 M551.69 M430.34 M288.97 M 有利子負債合計 —————— 純負債 ——————

ニュース

ナスダックが上昇、米国のインフレ率が3月に加速

What's Behind The Surge In Zentalis Stock? - Zentalis Pharmaceuticals (NASDAQ:ZNTL)

Wells Fargo、Zentalis株のカバレッジを目標株価5ドルで開始

Wells Fargo assumes coverage on Zentalis stock with $5 target

Zentalis Pharma CEO Eastland sells $21k in shares

Zentalis Pharma CMO Bruns sells $7998 in stock

ゼンタリス・ファーマシューティカルズのPAO、7.8千ドル相当の株式を売却

Zentalis Pharmaceuticals: Late Stage, Lots Of Cash, Crushed By The Market

Zentalis Pharmaceuticals: Hanging On For One Last Shot At PROC Approval (ZNTL)

Zentalis Pharmaceuticalsの株価目標、Leerink Partnersにより2ドルに引き下げ

Zentalis Pharmaceuticals stock price target lowered to $2 at Leerink Partners

Zentalis to present azenosertib data at cancer therapeutics conference